Cytox Limited


Cytox Limited is a UK company developing diagnostic and prognostic services for neurodegenerative disorders. We currently provide biomarker services to pharmaceutical industry clients conducting clinical trials with drugs for the treatment of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Our blood tests are used to predict which patients with MCI will develop AD, which allows treatment in the earliest stages of AD. The biomarkers are based on the cell cycle hypothesis of AD discovered by Dr. Zsuzsanna Nagy.